— Know what they know.
Not Investment Advice
Also trades as: 5CV.DE (XETRA) · $vol 1M · 5CV.F (FSX) · $vol 0M

CVAC NASDAQ

CureVac N.V.
1W: +7.4% 1M: -13.1% 3M: -16.3% 1Y: +42.6% 3Y: -28.1% 5Y: -95.5%
$4.66
Last traded 2025-12-31 — delisted
NASDAQ · Healthcare · Biotechnology · $1.0B mcap · 96M float · 1.22% daily turnover · Short 32% of daily vol

Balance Sheet Trends

Total Assets
$803M +1.8% ▲
5Y CAGR: +43.8%
Total Liabilities
$106M -60.8% ▼
5Y CAGR: -9.3%
Shareholders Equity
$697M +34.8% ▲
Cash & Investments
$485M +19.8% ▲
5Y CAGR: +72.1%
Total Debt
$39M -6.8% ▼
5Y CAGR: -13.2%
Net Debt
-$443M -22.8% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$1.3B$811M$496M$402M$482M
Short-Term Investments$3M$5M$4M$3M$4M
Cash & ST Investments$1.3B$816M$500M$405M$485M
Net Receivables$2M$54M$9M$40M$33M
Inventory$15M$56M$24M$25M$541K
Other Current Assets$0$8M$16M$8M$7M
Total Current Assets$1.4B$940M$584M$478M$526M
Property, Plant & Equip.$105M$200M$242M$279M$245M
Goodwill & Intangibles$14M$13M$32M$28M$25M
Long-Term Investments$1M$515K$0-$4K$0
Other Non-Current Assets$1M$1M$2M$2M$2M
Total Non-Current Assets$122M$218M$276M$310M$276M
Total Assets$1.5B$1.2B$860M$788M$803M
— Liabilities —
Accounts Payable$18M$122M$68M$48M$17M
Short-Term Debt$0$0$0$0$0
Deferred Revenue$158M$56M$37M$45M$0
Other Current Liabilities$56M$171M$45M$89M$32M
Total Current Liabilities$248M$358M$156M$186M$72M
Long-Term Debt$0$0$0$0$0
Other Non-Current Liab.$25M$87M$134M$0$0
Total Non-Current Liabilities$552M$112M$171M$85M$34M
Total Liabilities$800M$470M$327M$271M$106M
— Equity —
Common Stock$22M$22M$23M$27M$27M
Retained Earnings-$645M-$1.1B-$1.3B-$1.6B-$1.4B
Accumulated OCI$1.3B$1.7B$1.8B$2.1B$2.1B
Total Stockholders Equity$711M$688M$533M$517M$697M
Total Liabilities & Equity$1.5B$1.2B$860M$788M$803M
— Key Metrics —
Total Debt$30M$29M$42M$42M$39M
Net Debt-$1.3B-$783M-$454M-$361M-$443M
Total Investments$4M$5M$4M$3M$4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms